Stocks in the US have been falling in recent weeks due to disappointed expectations that there could be up to four rate reductions in 2025.
According to Julian Emanuel, Evercore ISI, investors can increase their odds of achieving outsized gains in January by sticking with names that have low momentum. These stocks tend, historically, to perform better than their peers who are high-momentum early in the calendar year.
He also recommends that you invest in small stocks in order to beat the January market.
Julian believes that smaller stock prices will remain high throughout this year, as Trump’s business-friendly policies and credit regulation take effect.
In a Friday research note, the firm informed clients that stocks offering buybacks usually start off the year in a positive note, especially when the Fed lowers interest rates.
Julian Emanuel says that Cleveland-Cliffs Inc. (NYSE: CLF), and Gentherm Inc. (NASDAQ:THRM) are two names which meet the three criteria, and should be owned heading into January.
Cleveland-Cliffs Inc
According to Evercore ISI analysts, Cleveland-Cliffs shareholders have had a difficult year. However, the beginning of 2019 will bring a new lease on life for this steel company.
He’s certainly not the only one who is a CLF bull.
Goldman Sachs experts gave Cleveland-Cliffs a rating of “buy” last week.
The $16 target price indicates a potential upside of more than 70% from this point.
CLF, the investment bank’s subsidiary, expects its self-help initiative aimed at controlling costs to be successful.
Cleveland-Cliffs is also a positive stock because of value-enhancing project that could drive earnings growth in 2025 and increase margins.
Goldman Sachs also has high hopes for Stelco’s acquisition by the company, valued at $2.5 billion.
CLF shares are not attractive to income investors because they don’t pay dividends.
Gentherm Inc
Gentherm, a stock in the automotive industry, also meets Evercore ISI criteria, and could therefore outperform other names this January.
Gentherm, like CLF has experienced a steep decline over the last ten months. It is currently trading at an attractive price.
JPMorgan recently upgraded Gentherm’s stock, citing solid performance as the reason for their change of mind.
The analyst Ryan Brinkman said that the company had benefited from Alfmeier’s acquisition in 2022, particularly through greater revenue synergies than anticipated due to go-to market improvements and quicker product innovation.
Analysts rate Gentherm’s shares as “overweight”. One analyst has predicted a potential upside of up to $68. This would translate to 80% increase in the stock price from its current level.
THRM does not offer a dividend either.
The post These two stocks will outperform the market in January could be updated as new information becomes available
This site is for entertainment only. Click here to read more
